TLR4 and necrotizing enterocolitis: Moreover, among HMOs, sialylated oligosaccharides at their physiological levels, have been reported to improve survival in rat NEC models, by suppressing TLR4-mediated inflammation, while also downregulating the NLRP3 inflammasome [120].